Elite (ELTP) facts below -
This OTC stock is actually generating revenues and making a profit!
Elite Pharmaceutical (ELTP)!!! Should be trading at least in the 40 cent range or higher, IMO!
Reporting quarterly results in the next week.
ELTP - generic Adderall IR IQVIA $400 million market - LAUNCHED and generating REVENUE!
revenue
ELTP - generic Adderall IR IQVIA $1.5 Billion market - LAUNCHED and generating REVENUE!
The competitive generic Adderall market (IR & XR) is almost $2 billion, with a CAGR of between 6% and 8.5%.
Using a conservative mid-point for the CAGR and a prorated market share suggests Elite could reach $225,000,000 scaling up to peak revenues (3-5 years) with just with Adderall revenues.
Then you can also add in ELTP's other approved products (Isradipine, Loxapine, Phentermine, generic Revia, generic Bontril, generic Surmontil, generic Dantrium).
AND, there will be other sources of revenue generated by their R&D efforts.
Working on a new product-
Quote from CEO Nasrat - “This is an outstanding product for us once we get an approval because we will be the fifth in this arena, and even if there were more people than that and we've got just 10% of that market, that's $160 million, a $160 million in revenues will do wonders to Elite stock.
Profit Last Quarter $2.5 Million and continues to grow quarter after quarter!
CASH FLOW POSITIVE!
Reoccurring Profits
61% YOY gains.
CASH FLOW POSITIVE 2 quarters in a row.
Forward PE 5.6??? That is way too low!
6 straight quarters of double and triple digit gains YOY.
Elite doing All R&D in-house currently.
Elite has competitive advantage on high entry barrier ER formulas.
Elite streamlining using SAP technology.
Debt to market cap : 7%
“Elite is attractive for Merger or BuyOut”.
New Equipment for production line - NEW 30 cubic foot V-blender. NEW higher speed tablet press. Facility upgrades. One shift can do 300 million capsules a month.
Upgraded the Packaging Line - capacity increased by 25%.
ELITE's partners Lannett, Glenmark, and Tagi continue to penetrate the markets.
Walgreens - Largest Customer - 15% of market
$75 million tax credit, no taxes on first $75 million profit.
49% profitability.
Partnerships, contract development, licensing opportunities, contract manufacturing, new ANDAs, potential for merger, potential for buy out, etc!!!
All of this has been posted here before. As always, do your own due dilegence and invest wisely!
